Analyst Ratings for Assertio Therapeutics (ASRT) [Buys]

ASRT Rating Summary

  |   Expand Research on ASRT
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: N/A
Rating Score: 5 / 10   Percentile Rank: 50%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
4/9/2021 Gabelli Kevin Kendra Upgrade Buy
(Hold)
N/A
(N/A)
0.59
(1.73)
193.22% Details
6/3/2020 Brookline Capital Markets Sally Yanchus New Coverage Buy
(N/A)
3.50
(N/A)
1.00
(1.73)
73% Details